Michelle Robertson

2019 - Momenta Pharmaceuticals

In 2019, Michelle Robertson earned a total compensation of $991.8K as Chief Financial Officer at Momenta Pharmaceuticals, a 18% decrease compared to previous year.

Compensation breakdown

Option Awards$627,910
Salary$350,000
Other$13,853
Total$991,763

Robertson received $627.9K in option awards, accounting for 63% of the total pay in 2019.

Robertson also received $350K in salary and $13.9K in other compensation.

Rankings

In 2019, Michelle Robertson's compensation ranked 9,310th out of 13,971 executives tracked by ExecPay. In other words, Robertson earned more than 33.4% of executives.

ClassificationRankingPercentile
All
9,310
out of 13,971
33rd
Division
Manufacturing
3,733
out of 5,701
35th
Major group
Chemicals And Allied Products
1,417
out of 2,200
36th
Industry group
Drugs
1,206
out of 1,886
36th
Industry
Biological Products, Except Diagnostic Substances
270
out of 389
31st

Pay ratio

Michelle Robertson's Pay$991,763
Median Employee's Pay$210,742
Pay Ratio

5

to 1

In 2019, the annual total compensation of Michelle Robertson was $991,763.

The annual total compensation of the median employee at Momenta Pharmaceuticals was $210,742.

The ratio of Michelle Robertson's pay to the pay of median employee was therefore 5 to one.

Source: SEC filing on April 24, 2020.

Robertson's colleagues

We found four more compensation records of executives who worked with Michelle Robertson at Momenta Pharmaceuticals in 2019.

2019

Craig Wheeler

Momenta Pharmaceuticals

Chief Executive Officer

2019

Young Kwon

Momenta Pharmaceuticals

Chief Business Officer

2019

Santiago Arroyo

Momenta Pharmaceuticals

Chief Medical Officer

2019

Anthony Manning

Momenta Pharmaceuticals

Chief Scientific Officer

News

In-depth

You may also like